SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following its announced all-stock merger with TAE Technologies, a nuclear fusion energy company, a deal valued at over $6 billion. This strategic shift is electrifying community discussions, with many hailing it as a pioneering entry into fusion and AI power with immense growth potential, while skeptics decry it as another highly speculative venture with questionable long-term fundamentals. The move has amplified polarized debate, focusing on the company's unexpected pivot into cutting-edge energy technology.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the crypto community keenly anticipates the Bank of Japan's interest rate decision, generating widespread discussion about potential market shifts and broader volatility. This macro event aligns with continued strong inflows into XRP Spot ETFs and reports of significant supply reduction on exchanges, suggesting institutional accumulation and a potential supply shock. Despite these developments, community sentiment remains split, with dedicated holders confident in long-term utility while others voice frustration over current price performance and market correlation.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is a top trending stock following its recent earnings report, which, despite beating analyst estimates, revealed significant concerns over declining margins, weak China sales, and a drop in direct-to-consumer business. The market is reacting sharply to cautious forward guidance, with many in the community voicing skepticism about management's ability to drive a turnaround amid fierce competition from brands like On Running and Hoka. While some investors view the sell-off as an "oversold value play," the prevailing sentiment reflects worries about the brand's long-term growth trajectory and profitability.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending downward sharply due to widespread forecasts of unseasonably warm winter weather, prompting a "torch-mas" narrative that is driving natural gas prices lower. This rapid decline has intensified community division; while many are labeling BOIL a "junk" ETF because of its inherent decay, others see the current oversold conditions as a prime buying opportunity ahead of anticipated colder January temperatures. The ETF's notorious volatility, often dubbed the "widowmaker," underscores the high-risk nature of trading this weather-sensitive instrument.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber (WYFI) is trending following news of a significant 10-year, 40 MW colocation agreement with Nscale for its NC-1 data center campus, representing approximately $865 million in contract value for AI infrastructure. The community is buzzing with excitement over this substantial deal, anticipating strong price momentum and a potential short squeeze given the stock's low float. Investors are keenly discussing the company's enhanced position within the booming AI data center sector, citing recent analyst upgrades and the long-term implications of this contract.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave (CRWV) is trending following its announcement of joining the U.S. Department of Energy's Genesis Mission, positioning its AI cloud for national research and security initiatives. This development has ignited fervent debate among investors, with optimists viewing it as crucial government validation and a strong catalyst for a significant rebound and potential short squeeze. Skeptics, however, maintain concerns about the company's debt and recent insider selling, questioning the long-term impact of the news on its valuation within the volatile AI infrastructure sector.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

4CHAN CRYPTO is trending as meme coin enthusiasts believe capital is rotating back to this 'source code' asset from other major memes. The community is enthusiastically 'hodling' and 'DCAing,' driven by its unique '13 zeroes' tokenomics and a strong conviction that it represents the 'Bitcoin of memecoins' poised for an epic run in the anticipated meme supercycle.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is actively traded amid extreme volatility in natural gas prices, as recent weather forecast updates often swing from cold snaps to milder outlooks, driving rapid price movements. The community is sharply divided, with many seeing natural gas as overbought given high production and storage, making inverse plays like KOLD a focus for those anticipating a price correction.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is a hot topic, with recent analyst upgrades and its CEO's discussion of strategic partnerships, like OpenTable, driving conversation around its voice AI potential. Bullish investors are advocating for accumulation, viewing current prices as a deep value opportunity in the burgeoning agentic AI space. Conversely, a significant portion of the community expresses frustration over the stock's persistent price weakness and lack of sustained upward momentum, fueling a contentious debate on its near-term prospects.

Derive is a decentralized protocol that creates programmable onchain options, perpetuals, and structured products.   Derive is deployed and operates on Derive Chain, an Ethereum rollup built using the OP stack and is the home of the Derive Protocol. It is a permission-less smart contract platform.  The Derive DAO earns trading fees from the Derive Protocol and gas fees from the Derive Chain, governed by DRV token holders. Trading fees accrue to an insurance fund to foster robustness of the protocol and rollup.  Derive has built an AI-powered trading app built for pro traders. In collaboration with Messari, Derive Pro translates market views into trades. The agent then prepares transactions for users and leverages smart contract wallets to make trades one-click, gasless and chainless. The app will support spot, perps and options trading on Derive, and will also plug in to spot AMMs on L2s like Optimism, Arbitrum and Base.

Derive

Derive (DRV) is trending due to its recent collaboration with Synthetix, focusing on developing derivatives on the Ethereum Layer 1 network, signaling significant ecosystem expansion. Community members are actively discussing DRV's robust Onchain Matrix treasury loop, including ongoing buybacks and rewards for holders, alongside perceived strong chart action, with many feeling the asset is currently undervalued.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ETF Fundamental Report for IWM

Below is Validea's ETF fundamental report for iShares Russell 2000 ETF (IWM). The report looks at IWM's exposure to the major investing factors including value, quality, momentum and low volatility...

5 Momentum ETFs With More Room to Run in 2026

AI strength, solid earnings, and upbeat 2026 forecasts fuel momentum plays. These five ETFs -- GDXJ, SLV, KBE, MDYV & IWM -- may still have room to run.

Tracking the Top-Performing Russell 2000 Stocks Against the Zacks Rank

Adding to the unusually strong performance of the Russell 2000 this year, these top performers may certainly serve as stocks to add to your watchlist

Zacks Investment Ideas feature highlights: Carvana, Lennar, Bank of America, Newmont Mining and the Russell 2000 Index ETF

A widely expected Fed rate cut puts Powell's tone in focus as investors watch how Carvana and other rate-sensitive names react.

December FOMC Preview: Rate Cut Priced in but Tone is Everything

On Wednesday, the Federal Reserve will take center stage. With a rate cut widely expected, the real story will be expectations for 2026 and how the Fed balances softening employment data with ongoing economic strength.

<ul class="summary-bullets"><li>The S&amp;P 500 is only trading within a 100-point range from its all-time highs.</li><li>Retail traders have bearish retail positioning on SPY and QQQ amid skepticism over Nvidia’s chip-export approval to China.</li><li>Siegel expects a flat December performance but sees potential for healthy consolidation and rotation into smaller, rate-sensitive stocks.</li></ul>U.S. stock futures traded narrowly mixed early Tuesday, underscoring the indecision among traders as they await the Federal Reserve’s final rate decision for the year. Risk sentiment could also take a beating from President Donald Trump’s renewed tariff salvo fired at North American neighbors, Mexico and Canada, as well as India.Writing on Truth Social, Trump&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/115686410399815717">berated</a> Mexico for violating the Water Treaty and issued an ultimatum: if Mexico does not release the agreed-upon water quota, a 5% tariff will be imposed. Separately, while speaking at a White House event, the president said he was mulling fresh tariffs on agricultural products such as Indian rice and Canadian fertilizer, Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-12-08/trump-eyes-tariffs-over-cheap-canadian-fertilizer-indian-rice">reported.</a>Traders may also sift through a couple of economic data points and some key earnings reports as they plot their next moves.WisdomTree Senior Economist Jeremy Siegel calls for a relatively flat performance in December as the markets digest the Fed’s message and wait for clarity on tariffs and policy heading into 2026. In his weekly commentary, the economist and strategist said, “The one seasonal I do give more weight to is the short window between Christmas and New Year’s, the so-called Santa Claus rally.”The strategist said the consolidation he predicts would be healthy "if it comes with a subtle rotation — away from over-owned megacaps and toward smaller, rate-sensitive names that benefit most from the first leg of easing.”<h2 class="st-heading-2">How Futures Are Trading</h2>As of 2:40 a.m. ET on Tuesday, the Nasdaq 100 futures, S&amp;P 500, and Dow futures were marginally higher, while the Russell 2000 futures traded down 0.08%.On Stocktwits, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, and the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, remained ‘bearish’ as of early Tuesday. The message volume on the SPY and QQQ ETF streams remained at ‘normal’ and ‘high’ levels, respectively.Most observers did not view the Trump administration’s decision to allow the export of Nvidia’s H200 chips to China favorably, as they doubted China's uptake.<stembedurl>https://stocktwits.com/newsman07336/message/638555952</stembedurl>Another user stated that a Santa Claus rally, which gives the market a year-end lift, is unlikely this year.<stembedurl>https://stocktwits.com/8Inevitableoutcome/message/638552484</stembedurl><h2 class="st-heading-2">How Markets Fared Monday</h2>Stocks were in a “wait-and-watch” mode on Monday amid uncertainty surrounding the Fed decision, due Wednesday. All but the IT sector closed in the red, with communication services, consumer discretionary, material, healthcare, and utility stocks ending markedly lower. In the process, the S&amp;P 500 Index moved away from its all-time high of 6,920.34 before settling at 6,846.51.The QQQ, SPY, and&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> fell 0.19%, 0.32% and 0.39%, respectively, while the&nbsp;<a href="https://stocktwits.com/symbol/IWM">iShares Russell 2000 ETF (IWM)</a> closed marginally higher.<h2 class="st-heading-2">Key Catalysts To Watch Out For</h2>The National Federation of Independent Business (NFIB) is scheduled to release its optimism index for November at 6 a.m. ET. The index, which measures optimism among small businesses, is expected to remain unchanged at 98.2.The Bureau of Labor Statistics is set to release the results of the Job Openings and Labor Turnover (JOLTS) survey for October at 10 a.m. ET. The reading will be closely watched, as the government suspended the release of the September report due to the shutdown.Notable names reporting earnings on Tuesday are AutoZone (AZO), G-III Apparel (GIII), Sailpoint (SAIL), AeroVironment (AVAV), Casey’s General (CASY), Cracker Barrel (CBRL), and GameStop (GME).&nbsp;<h2 class="st-heading-2">How Other Markets Fared</h2>The Asian markets fell across the board as the Fed decision loomed, while Japanese stocks closed modestly higher, supported by the yen's weakness. In a major central bank decision from the region, the Reserve Bank of Australia announced a pause, in line with expectations, and hinted that further easing is unlikely.The greenback was weaker against most major currencies, except the yen. The 10-year U.S. Treasury note yield was little changed early Tuesday after rising 3.3 points to 4.172% in the previous session. Among commodities, crude oil futures fell modestly, with the WTI crude now trading below $59 level, and gold futures also eased.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/what-a-post-powell-fed-may-look-like-under-trump-favorite-kevin-hassett/cLIYqZPREm7">What A Post-Powell Federal Reserve May Look Like Under Trump Favorite Kevin Hassett</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on October 01, 2025, in New York City.  

Nasdaq, S&P 500 Futures Freeze As Fresh Trump Tariff Threats On Mexico, India Collide With Fed Jitters — Strategist Warns Santa Rally Looks Unlikely

The muted action reflects a broader sense of indecision across markets, with traders weighing the central bank’s interest-rate path against the latest geopolitical and trade uncertainties.

Equity

The muted action reflects a broader sense of indecision across markets, with traders weighing the central bank’s interest-rate path against the latest geopolitical and trade uncertainties.


Why High-Income Seekers Are Turning to Autocallable ETFs

We explain how Autocallable ETFs work and who they are for.


<ul class="summary-bullets"><li>H.C. Wainwright conservatively expects approval by the middle of 2026 and sees the shares trading well into the year-end.</li><li>Capricor’s bumper rally on Wednesday helped the stock turn green for the year.</li><li>Retail sees the stock as a long-term winner following the Phase 3 results.</li></ul>Two decades after its modest beginnings and more than a decade after becoming a public company, San Diego, California-based Capricor Therapeutics made another stride toward becoming a commercial-stage company. After a failed first try, the small-cap biotech is hoping to push its experimental cell-therapy for a rare genetic muscular disorder past the finish line without any hiccups.Wall Street analysts and the investment community received the recently released late-stage trial data for the treatment candidate well. While sell-side analysts were generous with their price target hikes, signaling their excitement toward the data, investors sent the stock up by over 530% at one point in Wednesday’s session. The initial euphoria faded slightly, but didn’t die out, as<a href="https://stocktwits.com/symbol/CAPR">&nbsp;Capricor’s stock</a> had enough verve to finish the day up 371% at $29.96,&nbsp;ending at an eight-year high and marking its best day ever.<img src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_2_28_48_AM_png_599beb080a.webp" alt="Screenshot 2025-12-04 at 2.28.48 AM.png">Source: Koyfin<h2 class="st-heading-2">What Fueled CAPR’s Stratospheric Rally</h2>Wednesday, before the market opened, Capricor reported positive topline results from the Phase 3 study, dubbed HOPE-3, evaluating its Duchenne Muscular Dystrophy (DMD) cell therapy candidate, Deramiocel.-The primary endpoint, measured as the performance of upper limb (PUL), was met — showing statistically and clinically meaningful treatment effects in 54% of the patients.-The key secondary endpoint of “Left Ventricular Ejection Fraction (LVEF),” a measure of heart health, was also met.&nbsp;Thus, Deramiocel was shown to produce significant skeletal and cardiac benefits, supporting its credentials as a potential “first-in-class therapy” for Duchenne cardiomyopathy, the leading cause of mortality in DMD. The trial also gave the cell therapy a clean chit for its safety and tolerability.Capricor said it would submit the detailed results from the HOPE-3 study at a future scientific meeting and for publication in a peer-reviewed journal.Earlier in July, the FDA shot down Capricor’s initial application for Deramiocel, issuing a complete response letter (CRL) — a notice that an application cannot be approved in its current form. The agency expressed wariness about the company's efficacy data at the time and sought additional data. Industry experts saw it as a signal that the new leadership at the FDA could be veering toward a cautious approach.&nbsp;&nbsp;CEO Linda Marbán said the study results, in addition to the evidence from the HOPE-2 and HOPE-2 OLE studies, would address the clinical issues in the CRL and support regulatory approval.DMD is caused by a mutation in the DMD gene that prevents the body from producing the protein dystrophin. A lack of dystrophin hits muscle fibres, leading to muscle damage and loss.&nbsp;<h2 class="st-heading-2">What’s At Stake For Capricor</h2>According to Grand View Research, the DMD drugs<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.grandviewresearch.com/industry-analysis/duchenne-muscular-dystrophy-dmd-drugs-market">&nbsp;market</a> is expected to grow at a compounded annual growth rate (CAGR) of 16.8% from 2024, reaching $9.91 billion in 2030. North America’s revenue share was at 45% in 2023. Global Data, meanwhile, has a more muted forecast, predicting a $5.2 billion market opportunity in 2033.&nbsp;<img src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_3_25_08_AM_png_f4173223fa.webp" alt="Screenshot 2025-12-04 at 3.25.08 AM.png">Source: Grandview ResearchThe DMD market is currently led by Sarepta, which has a gene-replacement therapy called Eteplirsen. Elevidys, a one-time single-dose gene transfer therapy, was approved in June 2023, and its label was expanded a year later to include patients ages four and older. The gene therapy generated $131.5 million in revenue for Sarepta in the third quarter.Capricor’s Deramiocel differs from Elevidys in that it is a cell therapy that administers the patient's cardiosphere-derived cells, which secrete exosomes. The latter uses a manufactured gene for delivering the micro-dysrophin gene.Sarepta also has three FDA-approved exon-skipping therapies, Exondys 51, Amondys 45 and Vyondys 53, and it is also currently working on RNA therapies.<h2 class="st-heading-2">Big Price Target Bumps</h2>Following the data, H.C. Wainwright upped the price target for Capricor's stock to $60 from $24 and kept a 'Buy' rating, the Fly reported. The firm called the data a "decisive" win. With 78% of participants having underlying cardiomyopathy, the trial results addressed FDA concerns about sample size, the firm said. It conservatively expects approval by the middle of 2026 and sees the shares trading well into the year-end.Alliance Global called the data "unequivocally and wholly positive" and removed the speculative tag from the stock. The firm hiked its price target for the stock to $48 from $16.<h2 class="st-heading-2">Retail Convinced Of Capricor Opportunity</h2>On Stocktwits, retail investors held an 'extremely bullish' stance on Capricor stock as of early Thursday. The message volume on the stream was 'extremely high as well.A majority of retail traders are sold on Capricor's long-term potential. An ongoing Stocktwits poll asking users "What's your move on $CAPR after this Phase 3 win?" found that 53% of respondents said "This is legit — CAPR becomes a long-term winner," while 18% remained on the sidelines, waiting for approval to come through. About 29% shrugged off the rally as an "overreaction."<a href="https://stocktwits.com/StocktwitsPolls/message/638043423"><img src="https://news.stocktwits-cdn.com/CAPR_Stocktwits_poll_png_bc7624531b.webp" alt="CAPR Stocktwits poll.png"></a>CAPR stock has&nbsp;soared about 117% this year, as Wednesday's bumper rally helped it recoup all its losses to that point and turn green for the year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/core-weave-vs-nebius-ai-infra-s-breakout-duo-backed-by-nvidia-is-outrunning-big-tech/cLIXYiKRE12">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/whispers-of-an-apple-deal-rebooted-intel-s-year/cLIXAvERE1L">Whispers Of An Apple Deal Rebooted Intel’s Year — Now The Market’s Asking Whether The Old Chip Giant Can Rise Again</a>

In this photo illustration, the lCapricor Therapeutics logo is seen displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Capricor’s Red-Hot Rally Has Wall Street And Retail Hooked — And Fresh DMD Data Could Keep Fueling The Fire

 DMD patients may soon gain access to a therapy that not only targets muscle decline but also tackles heart complications — the leading cause of death in this rare genetic disorder.

ETFs to Benefit From Rate Cut Bets and Upbeat Forecasts

ETFs to watch as Wall Street turns upbeat, with bullish forecasts putting the S&P 500 on track for 8,000 by 2026.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

IWM
iShares Russell 2000 ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IWM News

IWMiShares Russell 2000 ETF